成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 616-47-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 616-47-7
Chemical Structure| 616-47-7
Structure of 616-47-7 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 616-47-7 ]

Related Doc. of [ 616-47-7 ]

Alternatived Products of [ 616-47-7 ]
Product Citations

Product Citations      Expand+

McGrath, Andrew ; Huang, Haiyan ; Brazeau, Jean-Francois , et al. DOI: PubMed ID:

Abstract: Protein degradation using proteolysis targeting chimeras (PROTACs) represents a promising therapeutic strategy. PROTACs are heterobifunctional molecules that consist of a target-binding moiety and an E3 ligase binding moiety, connected by a linker. These fragments are frequently united via amide bonds. While straightforward to synthesize, amides may impart suboptimal drug properties to the overall molecule. From a systems level perspective, we envisioned that the potency of PROTACs could be modulated through selection of reaction conditions-wherein different catalysts produce distinct linkers from the same two building blocks. We present a suite of BRD4 PROTAC degraders prepared via four new amine?acid coupling reactions alongside the classic amide coupling. Our findings reveal that variations in reaction conditions affect the physicochemical properties of PROTACs, resulting in a spectrum of properties. Notably, several new PROTACs demonstrated enhanced BRD4 degradation efficacy compared to those employing amide linkers, emphasizing the potential of systems chemistry as a therapeutic optimization strategy.

Purchased from AmBeed: ; ;

Anushree Mondal ; Pronay Roy ; Jaclyn Carrannatto , et al. DOI: PubMed ID:

Abstract: The prenylated-flavin mononucleotide-dependent decarboxylases (also known as UbiD-like enzymes) are the most recently discovered family of decarboxylases. The modified flavin facilitates the decarboxylation of unsaturated carboxylic acids through a novel mechanism involving 1,3-dipolar cyclo-addition chemistry. UbiD-like enzymes have attracted considerable interest for biocatalysis applications due to their ability to catalyse (de)carboxylation reactions on a broad range of aromatic substrates at otherwise unreactive carbon centres. There are now ~35[thin space (1/6-em)]000 protein sequences annotated as hypothetical UbiD-like enzymes. Sequence similarity network analyses of the UbiD protein family suggests that there are likely dozens of distinct decarboxylase enzymes represented within this family. Furthermore, many of the enzymes so far characterized can decarboxylate a broad range of substrates. Here we describe a strategy to identify potential substrates of UbiD-like enzymes based on detecting enzyme-catalysed solvent deuterium exchange into potential substrates. Using ferulic acid decarboxylase (FDC) as a model system, we tested a diverse range of aromatic and heterocyclic molecules for their ability to undergo enzyme-catalysed H/D exchange in deuterated buffer. We found that FDC catalyses H/D exchange, albeit at generally very low levels, into a wide range of small, aromatic molecules that have little resemblance to its physiological substrate. In contrast, the sub-set of aromatic carboxylic acids that are substrates for FDC-catalysed decarboxylation is much smaller. We discuss the implications of these findings for screening uncharacterized UbiD-like enzymes for novel (de)carboxylase activity.

Purchased from AmBeed: ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;

Product Details of [ 616-47-7 ]

CAS No. :616-47-7 MDL No. :MFCD00005292
Formula : C4H6N2 Boiling Point : -
Linear Structure Formula :(CH3)NC3H3N InChI Key :MCTWTZJPVLRJOU-UHFFFAOYSA-N
M.W : 82.10 Pubchem ID :1390
Synonyms :
Chemical Name :1-Methyl-1H-imidazole

Calculated chemistry of [ 616-47-7 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 6
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.25
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 23.49
TPSA : 17.82 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.84 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.15
Log Po/w (XLOGP3) : -0.06
Log Po/w (WLOGP) : 0.42
Log Po/w (MLOGP) : -0.47
Log Po/w (SILICOS-IT) : 0.51
Consensus Log Po/w : 0.31

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.93
Solubility : 9.69 mg/ml ; 0.118 mol/l
Class : Very soluble
Log S (Ali) : 0.14
Solubility : 113.0 mg/ml ; 1.37 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -0.68
Solubility : 17.1 mg/ml ; 0.208 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 616-47-7 ]

Signal Word:Danger Class:8,6.1
Precautionary Statements:P210-P264-P270-P280-P301+P312+P330-P301+P330+P331-P303+P361+P353-P304+P340+P310-P305+P351+P338+P310-P361+P364-P370+P378-P403+P235-P405-P501 UN#:2922
Hazard Statements:H227-H302-H311-H314 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 616-47-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 616-47-7 ]
  • Downstream synthetic route of [ 616-47-7 ]

[ 616-47-7 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 616-47-7 ]
  • [ 79-22-1 ]
  • [ 62366-53-4 ]
YieldReaction ConditionsOperation in experiment
73% With triethylamine In acetonitrile at -20 - 30℃; for 12.5 h; Inert atmosphere After replacing the inside of a 100 mL three-necked flask with an argon atmosphere, 22 mL of acetonitrile and 6.3 mL of methyl chloroformate were added and the mixture was cooled to -20 ° C. To this solution, a solution of 3.3 g of 1-methyl-1H-imidazole and 6.8 mL of triethylamine in 8 mL of acetonitrile was added in 30 minutes, followed by stirring at room temperature for 12 hours. After adding 50 mL of ethyl acetate to the reaction solution, insoluble matter was filtered off, and the residue was washed with 50 mL of ethyl acetate. The filtrate and the washing solution were combined, concentrated under reduced pressure,the concentrated residue was purified by column chromatography(Silica gel, hexane / ethyl acetate) to obtain 4.2 g (yield: 73percent) of methyl 1-methyl-1H-imidazole-2-carboxylate.
Reference: [1] Patent: JP2017/66077, 2017, A, . Location in patent: Paragraph 0059
  • 2
  • [ 616-47-7 ]
  • [ 67-56-1 ]
  • [ 68-12-2 ]
  • [ 62366-53-4 ]
  • [ 13750-81-7 ]
YieldReaction ConditionsOperation in experiment
79%
Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.5 h;
Stage #2: at -78 - 20℃; for 2 h;
General procedure: n-BuLi (1.67 M solution in hexane, 1.3 mL, 2.2 mmol) was added dropwise into a solution of p-bromoanisole (383 mg, 2.0 mmol) in THF (3 mL) at -78 °C for 30 min. Then, DMF (0.22 mL, 2.2 mmol) was added to the mixture and the obtained mixture was stirred at rt. After 2 h at the same temperature, THF was removed. Then, MeOH (3 mL) was added to the residue and the mixture was stirred at room temperature. After 30 min, I2 (1523 mg, 6 mmol) and K2CO3 (829 mg, 6 mmol) were added at 0 °C and the obtained mixture was stirred for 22 h at rt. The reaction mixture was quenched with satd aq Na2SO3 (5 mL) and was extracted with CHCl3 (3.x.20 mL). The organic layer was washed with brine and dried over Na2SO4 to provide methyl 4-methoxy-1-benzoate in 82percent yield. If necessary, the product was purified by short column chromatography (SiO2:hexane:EtOAc=9:1) to give pure methyl 4-methoxybenzoate as a colorless oil.
Reference: [1] Tetrahedron, 2012, vol. 68, # 24, p. 4701 - 4709
  • 3
  • [ 616-47-7 ]
  • [ 79-22-1 ]
  • [ 62366-53-4 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1983, # 8, p. 1913 - 1941
  • 4
  • [ 616-47-7 ]
  • [ 75-09-2 ]
  • [ 79917-88-7 ]
Reference: [1] New Journal of Chemistry, 2012, vol. 36, # 3, p. 702 - 722
  • 5
  • [ 616-47-7 ]
  • [ 74-87-3 ]
  • [ 79917-88-7 ]
Reference: [1] Journal of Physical Chemistry B, 2005, vol. 109, # 7, p. 2942 - 2948
Recommend Products
Same Skeleton Products
Historical Records

Related Parent Nucleus of
[ 616-47-7 ]

Imidazoles

Chemical Structure| 288-32-4

[ 288-32-4 ]

1H-Imidazole

Similarity: 0.87

Chemical Structure| 79917-88-7

[ 79917-88-7 ]

1,3-Dimethyl-1H-imidazol-3-ium chloride

Similarity: 0.85

Chemical Structure| 1467-16-9

[ 1467-16-9 ]

1H-Imidazole hydrochloride

Similarity: 0.83

Chemical Structure| 84661-56-3

[ 84661-56-3 ]

Di(1H-imidazol-1-yl)methane

Similarity: 0.82

Chemical Structure| 7098-07-9

[ 7098-07-9 ]

1-Ethyl-1H-imidazole

Similarity: 0.79

; ;